Cambridge, MA, December 18, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has been named to the 2023 Fortune Impact 20 list. The selection tabs TriNetX as one of the top 20 venture and private equity-backed companies leveraging’ innovative tools and solutions that make a significant impact on people’s lives.

“We are extremely proud to be recognized among this prestigious list of innovative companies,” said Gadi Lachman, Chief Executive Officer of TriNetX. “Our platform has become a critical part of clinical trial machinery for most of the world’s largest pharmaceutical organizations. We are honored to be recognized for our ongoing efforts to improve diversity in clinical trials.

TriNetX was selected for its impact in recruiting diverse populations for clinical trials – a persistent challenge hindering drug development and worsening health disparities. With a database of over 250 million patients from over 30 countries, the TriNetX platform empowers pharmaceutical companies to broaden their clinical trial enrollment and identify the most representative cohort for a given trial. In addition to supporting diversity metrics through data, TrNetX is pushing boundaries by leveraging machine learning to identify restrictive trial criteria and common constraints that impact diversity across studies and trial protocols.

“While we have taken steps in the right direction, we continue to strive to advance clinical trial diversity beyond providing data and by changing the process and design of trials from their inception,” said Lachman.

The Fortune Impact 20 list spotlights companies actively addressing critical social and environmental challenges demonstrating revenue growth and profit potential. The selection process, conducted by a distinguished committee, evaluated companies based on four criteria: potential impact, business viability, innovation and leadership, and track record.

To learn more, visit Advancing Diversity, Equity, and Inclusion with Data.


About TriNetX, LLC

TriNetX is a global network of healthcare organizations and life sciences companies driving real-world research to accelerate the development of new therapies. Through its self-service, HIPAA, GDPR, and LGPD-compliant platform of federated EHR, datasets, and consulting partnerships, TriNetX puts the power of real-world data into the hands of its worldwide community to improve protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation. For more information, visit TriNetX at or follow @TriNetX on Twitter.

Media Contact

Michelle Fleming